TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

39 hedge funds and large institutions have $70.6M invested in Theriva Biologics in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.1M
2
+$599K
3
+$481K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$299K
5
Citadel Advisors
Citadel Advisors
Florida
+$243K

Top Sellers

1
-$756K
2
-$424K
3
-$272K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$238K
5
CS
Credit Suisse
Switzerland
-$213K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$78K
27
$70K
28
$68K
29
$60K
30
$58K
31
$57K
32
$42K
33
$38K
34
$36K
35
$34K
36
$34K
37
$29K
38
$25K
39
$20K
40
$9K
41
$9K
42
$8K
43
$6K
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3